Selected research
Market Analysis & Forecast
Global White Fungus Drugs Market Analysis and Forecast 2026-2032
Market perspective
The global White Fungus Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for White Fungus Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for White Fungus Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for White Fungus Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for White Fungus Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of White Fungus Drugs include Novartis, Merck and Co. Inc., Pfizer Inc., GlaxoSmithKline, Sigma-Aldrich Corporation, Sanofi-Aventis, Glenmark Pharmaceuticals Ltd, Enzon Pharmaceuticals and Bayer Healthcare, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for White Fungus Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of White Fungus Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for White Fungus Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the White Fungus Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global White Fungus Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for White Fungus Drugs sales, projected growth trends, production technology, application and end-user industry.
White Fungus Drugs Segment by Company
Novartis
Merck and Co. Inc.
Pfizer Inc.
GlaxoSmithKline
Sigma-Aldrich Corporation
Sanofi-Aventis
Glenmark Pharmaceuticals Ltd
Enzon Pharmaceuticals
Bayer Healthcare
Astellas Pharma Inc
Abbott Laboratories
White Fungus Drugs Segment by Type
Powdery Mildew Medications
Pest Control Medications
Bacterial Infection Drugs
White Fungus Drugs Segment by Application
Online Sales
Offline Sales
White Fungus Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global White Fungus Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of White Fungus Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of White Fungus Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of White Fungus Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of White Fungus Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, White Fungus Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powdery Mildew Medications
- Pest Control Medications
- Bacterial Infection Drugs
Applications
- Online Sales
- Offline Sales
Companies covered
- Novartis
- Merck and Co. Inc.
- Pfizer Inc.
- GlaxoSmithKline
- Sigma-Aldrich Corporation
- Sanofi-Aventis
- Glenmark Pharmaceuticals Ltd
- Enzon Pharmaceuticals
- Bayer Healthcare
- Astellas Pharma Inc
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 White Fungus Drugs Market by Type
- 1.2.1 Global White Fungus Drugs Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Powdery Mildew Medications
- 1.2.3 Pest Control Medications
- 1.2.4 Bacterial Infection Drugs
- 1.3 White Fungus Drugs Market by Application
- 1.3.1 Global White Fungus Drugs Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Online Sales
- 1.3.3 Offline Sales
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 White Fungus Drugs Market Dynamics
- 2.1 White Fungus Drugs Industry Trends
- 2.2 White Fungus Drugs Industry Drivers
- 2.3 White Fungus Drugs Industry Opportunities and Challenges
- 2.4 White Fungus Drugs Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global White Fungus Drugs Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global White Fungus Drugs Revenue by Region
- 3.2.1 Global White Fungus Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global White Fungus Drugs Revenue by Region (2021-2026)
- 3.2.3 Global White Fungus Drugs Revenue by Region (2027-2032)
- 3.2.4 Global White Fungus Drugs Revenue Market Share by Region (2021-2032)
- 3.3 Global White Fungus Drugs Sales Estimates and Forecasts 2021-2032
- 3.4 Global White Fungus Drugs Sales by Region
- 3.4.1 Global White Fungus Drugs Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global White Fungus Drugs Sales by Region (2021-2026)
- 3.4.3 Global White Fungus Drugs Sales by Region (2027-2032)
- 3.4.4 Global White Fungus Drugs Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global White Fungus Drugs Revenue by Manufacturers
- 4.1.1 Global White Fungus Drugs Revenue by Manufacturers (2021-2026)
- 4.1.2 Global White Fungus Drugs Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global White Fungus Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global White Fungus Drugs Sales by Manufacturers
- 4.2.1 Global White Fungus Drugs Sales by Manufacturers (2021-2026)
- 4.2.2 Global White Fungus Drugs Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global White Fungus Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global White Fungus Drugs Sales Price by Manufacturers (2021-2026)
- 4.4 Global White Fungus Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global White Fungus Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global White Fungus Drugs Manufacturers, Product Type & Application
- 4.7 Global White Fungus Drugs Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global White Fungus Drugs Market CR5 and HHI
- 4.8.2 2025 White Fungus Drugs Tier 1, Tier 2, and Tier 3
5 White Fungus Drugs Market by Type
- 5.1 Global White Fungus Drugs Revenue by Type
- 5.1.1 Global White Fungus Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global White Fungus Drugs Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global White Fungus Drugs Revenue Market Share by Type (2021-2032)
- 5.2 Global White Fungus Drugs Sales by Type
- 5.2.1 Global White Fungus Drugs Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global White Fungus Drugs Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global White Fungus Drugs Sales Market Share by Type (2021-2032)
- 5.3 Global White Fungus Drugs Price by Type
6 White Fungus Drugs Market by Application
- 6.1 Global White Fungus Drugs Revenue by Application
- 6.1.1 Global White Fungus Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global White Fungus Drugs Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global White Fungus Drugs Revenue Market Share by Application (2021-2032)
- 6.2 Global White Fungus Drugs Sales by Application
- 6.2.1 Global White Fungus Drugs Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global White Fungus Drugs Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global White Fungus Drugs Sales Market Share by Application (2021-2032)
- 6.3 Global White Fungus Drugs Price by Application
7 Company Profiles
- 7.1 Novartis
- 7.1.1 Novartis Company Information
- 7.1.2 Novartis Business Overview
- 7.1.3 Novartis White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Novartis White Fungus Drugs Product Portfolio
- 7.1.5 Novartis Recent Developments
- 7.2 Merck and Co. Inc.
- 7.2.1 Merck and Co. Inc. Company Information
- 7.2.2 Merck and Co. Inc. Business Overview
- 7.2.3 Merck and Co. Inc. White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Merck and Co. Inc. White Fungus Drugs Product Portfolio
- 7.2.5 Merck and Co. Inc. Recent Developments
- 7.3 Pfizer Inc.
- 7.3.1 Pfizer Inc. Company Information
- 7.3.2 Pfizer Inc. Business Overview
- 7.3.3 Pfizer Inc. White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Pfizer Inc. White Fungus Drugs Product Portfolio
- 7.3.5 Pfizer Inc. Recent Developments
- 7.4 GlaxoSmithKline
- 7.4.1 GlaxoSmithKline Company Information
- 7.4.2 GlaxoSmithKline Business Overview
- 7.4.3 GlaxoSmithKline White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 GlaxoSmithKline White Fungus Drugs Product Portfolio
- 7.4.5 GlaxoSmithKline Recent Developments
- 7.5 Sigma-Aldrich Corporation
- 7.5.1 Sigma-Aldrich Corporation Company Information
- 7.5.2 Sigma-Aldrich Corporation Business Overview
- 7.5.3 Sigma-Aldrich Corporation White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Sigma-Aldrich Corporation White Fungus Drugs Product Portfolio
- 7.5.5 Sigma-Aldrich Corporation Recent Developments
- 7.6 Sanofi-Aventis
- 7.6.1 Sanofi-Aventis Company Information
- 7.6.2 Sanofi-Aventis Business Overview
- 7.6.3 Sanofi-Aventis White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Sanofi-Aventis White Fungus Drugs Product Portfolio
- 7.6.5 Sanofi-Aventis Recent Developments
- 7.7 Glenmark Pharmaceuticals Ltd
- 7.7.1 Glenmark Pharmaceuticals Ltd Company Information
- 7.7.2 Glenmark Pharmaceuticals Ltd Business Overview
- 7.7.3 Glenmark Pharmaceuticals Ltd White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Glenmark Pharmaceuticals Ltd White Fungus Drugs Product Portfolio
- 7.7.5 Glenmark Pharmaceuticals Ltd Recent Developments
- 7.8 Enzon Pharmaceuticals
- 7.8.1 Enzon Pharmaceuticals Company Information
- 7.8.2 Enzon Pharmaceuticals Business Overview
- 7.8.3 Enzon Pharmaceuticals White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Enzon Pharmaceuticals White Fungus Drugs Product Portfolio
- 7.8.5 Enzon Pharmaceuticals Recent Developments
- 7.9 Bayer Healthcare
- 7.9.1 Bayer Healthcare Company Information
- 7.9.2 Bayer Healthcare Business Overview
- 7.9.3 Bayer Healthcare White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Bayer Healthcare White Fungus Drugs Product Portfolio
- 7.9.5 Bayer Healthcare Recent Developments
- 7.10 Astellas Pharma Inc
- 7.10.1 Astellas Pharma Inc Company Information
- 7.10.2 Astellas Pharma Inc Business Overview
- 7.10.3 Astellas Pharma Inc White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Astellas Pharma Inc White Fungus Drugs Product Portfolio
- 7.10.5 Astellas Pharma Inc Recent Developments
- 7.11 Abbott Laboratories
- 7.11.1 Abbott Laboratories Company Information
- 7.11.2 Abbott Laboratories Business Overview
- 7.11.3 Abbott Laboratories White Fungus Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Abbott Laboratories White Fungus Drugs Product Portfolio
- 7.11.5 Abbott Laboratories Recent Developments
8 North America
- 8.1 North America White Fungus Drugs Market Size by Type
- 8.1.1 North America White Fungus Drugs Revenue by Type (2021-2032)
- 8.1.2 North America White Fungus Drugs Sales by Type (2021-2032)
- 8.1.3 North America White Fungus Drugs Price by Type (2021-2032)
- 8.2 North America White Fungus Drugs Market Size by Application
- 8.2.1 North America White Fungus Drugs Revenue by Application (2021-2032)
- 8.2.2 North America White Fungus Drugs Sales by Application (2021-2032)
- 8.2.3 North America White Fungus Drugs Price by Application (2021-2032)
- 8.3 North America White Fungus Drugs Market Size by Country
- 8.3.1 North America White Fungus Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America White Fungus Drugs Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America White Fungus Drugs Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe White Fungus Drugs Market Size by Type
- 9.1.1 Europe White Fungus Drugs Revenue by Type (2021-2032)
- 9.1.2 Europe White Fungus Drugs Sales by Type (2021-2032)
- 9.1.3 Europe White Fungus Drugs Price by Type (2021-2032)
- 9.2 Europe White Fungus Drugs Market Size by Application
- 9.2.1 Europe White Fungus Drugs Revenue by Application (2021-2032)
- 9.2.2 Europe White Fungus Drugs Sales by Application (2021-2032)
- 9.2.3 Europe White Fungus Drugs Price by Application (2021-2032)
- 9.3 Europe White Fungus Drugs Market Size by Country
- 9.3.1 Europe White Fungus Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe White Fungus Drugs Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe White Fungus Drugs Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China White Fungus Drugs Market Size by Type
- 10.1.1 China White Fungus Drugs Revenue by Type (2021-2032)
- 10.1.2 China White Fungus Drugs Sales by Type (2021-2032)
- 10.1.3 China White Fungus Drugs Price by Type (2021-2032)
- 10.2 China White Fungus Drugs Market Size by Application
- 10.2.1 China White Fungus Drugs Revenue by Application (2021-2032)
- 10.2.2 China White Fungus Drugs Sales by Application (2021-2032)
- 10.2.3 China White Fungus Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia White Fungus Drugs Market Size by Type
- 11.1.1 Asia White Fungus Drugs Revenue by Type (2021-2032)
- 11.1.2 Asia White Fungus Drugs Sales by Type (2021-2032)
- 11.1.3 Asia White Fungus Drugs Price by Type (2021-2032)
- 11.2 Asia White Fungus Drugs Market Size by Application
- 11.2.1 Asia White Fungus Drugs Revenue by Application (2021-2032)
- 11.2.2 Asia White Fungus Drugs Sales by Application (2021-2032)
- 11.2.3 Asia White Fungus Drugs Price by Application (2021-2032)
- 11.3 Asia White Fungus Drugs Market Size by Country
- 11.3.1 Asia White Fungus Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia White Fungus Drugs Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia White Fungus Drugs Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA White Fungus Drugs Market Size by Type
- 12.1.1 SAMEA White Fungus Drugs Revenue by Type (2021-2032)
- 12.1.2 SAMEA White Fungus Drugs Sales by Type (2021-2032)
- 12.1.3 SAMEA White Fungus Drugs Price by Type (2021-2032)
- 12.2 SAMEA White Fungus Drugs Market Size by Application
- 12.2.1 SAMEA White Fungus Drugs Revenue by Application (2021-2032)
- 12.2.2 SAMEA White Fungus Drugs Sales by Application (2021-2032)
- 12.2.3 SAMEA White Fungus Drugs Price by Application (2021-2032)
- 12.3 SAMEA White Fungus Drugs Market Size by Country
- 12.3.1 SAMEA White Fungus Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA White Fungus Drugs Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA White Fungus Drugs Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 White Fungus Drugs Value Chain Analysis
- 13.1.1 White Fungus Drugs Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 White Fungus Drugs Production Mode & Process
- 13.2 White Fungus Drugs Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 White Fungus Drugs Distributors
- 13.2.3 White Fungus Drugs Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst